首页> 外国专利> TYROSINE PHOSPHORYLATION-DEFICIENT MUTANT CALMODULIN, PRODUCTION METHOD THEREOF AND USE OF SAME IN BIOLOGICAL METHODS

TYROSINE PHOSPHORYLATION-DEFICIENT MUTANT CALMODULIN, PRODUCTION METHOD THEREOF AND USE OF SAME IN BIOLOGICAL METHODS

机译:酪氨酸磷酸化不足的突变钙钙调蛋白,其生产方法及其在生物方法中的用途

摘要

Calmodulin-deficient mutant tyrosine phosphorylation, production process and its use in biological processes.; The invention provides a deficient in phosphorylation in at least one of the only two tyrosine residues of native CaM (CaM mutant Y99F, mutated CaM Y138F, CaM mutant Y99F / Y138F) mutant calmodulin protein (CaM) and method obtaining genetically engineered said mutated CaM. Applications that can be addressed with the mutated CaM of the present invention are very large, taking advantage has different physiological properties than the native CaM as cell signaling pathways which are involved phosphorylated forms of CaM in said removed mutated residues, among others, use in methods of identifying new inhibitors of CaM and to assess the effect of inhibitors of CaM already identified of great interest in the pharmaceutical field.
机译:钙调蛋白缺陷型突变体酪氨酸磷酸化,生产过程及其在生物过程中的用途。本发明提供了天然CaM(CaM突变体Y99F,突变的CaM Y138F,CaM突变体Y99F / Y138F)突变钙调蛋白(CaM)的仅有的两个酪氨酸残基中的至少一个的磷酸化不足,以及获得了基因工程改造的所述突变的CaM的方法。可以利用本发明的突变的CaM解决的应用非常大,利用具有与天然CaM不同的生理特性的细胞信号通路,因为所述细胞信号通路在所述去除的突变残基中涉及CaM的磷酸化形式,尤其是在方法中的使用。 CaM的新抑制剂的鉴定以及评估已经鉴定的CaM抑制剂的作用在制药领域引起了极大的兴趣。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号